Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 12, Issue 3, 1998, Pages 121-126

  Morris, Martha Clare ^a   Beckett, Laurel A ^b   Scherr, Paul A ^c   Hebert, Liesi E ^d   Bennett, David A ^a   Field, Terry S ^a   Evans, Denis A ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c Department of Medicine ^*  (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Alzheimer disease; Antioxidants; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; MULTIVITAMIN;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; DIET SUPPLEMENTATION; EDUCATION; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0032420027     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199809000-00001     Document Type: Article

References (29)

1. Adams J, Klaidman L, Odunze I, et al. Alzheimer's and Parkinson's disease: Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol Chem Neumpathol 1991;14:213-26.
2. Agbayewa M, Bruce V, Siemens V. Pyridoxine, ascorbic acid and thiamine in Alzheimer and comparison subjects. Can J Psych 1992; 37:661-2.
3. Albert M, Smith L, Scherr P, et al. The use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-78.
4. 10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neural 1994; 36:882-8.
5. Corral-Debrinski M, HortonT, Lott MT, et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 1994;15:471-6.
6. Esterbauer H, Dieber-Rotheneder M, Striegl G, et al. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 1991;53(suppl):314S-21S.
7. Evans D, Funkenstein H, Albert M, et al. Prevalence of Alzheimer's disease in a community population of older persons-higher than previously reported. JAMA 1989;262:2551-6.
8. Fuller W. PC CARP, statistical laboratory. Ames, Iowa: Iowa State University, 1986.
9. Haines A, Iliffe S, Morgan P, et al. Serum aluminum and zinc and other variables in patients with and without cognitive impairment in the community. Clinica Chimica Acta 1991;198:261-6.
10. Hankinson S, Stampfer M, Seddon J, et al. Nutrient intake and cataract extraction in women: a prospective study. Br Med J 1992;305:335-9.
11. Hebert L, Scherr P, Beckett L, et al. Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol 1992; 135:347-55.
12. Hebert L, Scherr P, Beckett L, et al. Age-specific incidence of clinically diagnosed Alzheimer's disease in a community population. JAMA 1995;273:1354-9.
13. Hollander M, Wolfe D. Non-parametric statistical methods. New York: Wiley, 1973.
14. Hsiao K, Johannsdottir R, Yunis W, et al. Vitamin E delays onset of neurologic disorder in transgenic (TG) mice expressing human amyloid precursor protein (APP) variants. Soc Neurosci Abstr 1994;20:1674.
15. Jackson C, Holland A, Williams C, et al. Vitamin E and Alzheimer's disease in subjects with Down's syndrome. JMent DefRes 1988;32:479-84.
16. Jeandel C, Nicolas M, Dubois F, et al. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 1989;35:275-82.
17. Kvale G, Bjelke E, Gart J. Dietary habits and lung cancer risk. Int J Cancer 1983;31:397-405.
18. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
19. Mehta C. STAT-EXACT. Cambridge, MA: CYTEL Software Corp., 1992.
20. Meocci P, MacGarvey U, Béai M. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neural 1994;36: 747-51.
21. Metcalfe T, Bowen D, Muller D. Vitamin E concentrations in human brain of patients with Alzheimer's, fetuses with Down's syndrome, centenarians, and controls. Neurochem Res 1989;14:1209-12.
22. Nes M, Sem S, Rousseau B, et al. Dietary intakes and nutritional status of old people with dementia living at home in Oslo. Enr J Clin Nutr 1988;42:581-93.
23. Rimm E, Stampfer M, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
24. Sano M, Ernesto C, Thomas R, Klauber M, Schafer K, Grundman M, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336:1216-22.
25. Seddon J, Ajani U, Sperduto R, et al. Dietary carotenoids, vitamins A,C, and E, and advanced age-related macular degeneration. JAMA 1994; 272:1413-20.
26. Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neural 1991;30:332-9.
27. Socci D, Arendash G. Chronic antioxidant treatment improves the cognitive function of aged rats. Soc Neurosci Abstr 1994;20:390.
28. Stampfer M, Hennekens C, Manson J, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-8.
29. Zaman Z, Roche S, Fielden P, et al. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 1992;21:91-4.